General pharmacology презентация

Содержание

Слайд 2

«All is a poison, all is a medicine; either depends on the dose» Paracelsus (1493-1541)

«All is a poison, all is a medicine;
either depends on the

dose»
Paracelsus
(1493-1541)
Слайд 3

Слайд 4

PHARMACOKINETICS PROCESSES: ► Absorption ►Distribution ►Binding /Localization /Storage ►Biotransformation ►Elimination

PHARMACOKINETICS PROCESSES:

► Absorption
►Distribution
►Binding /Localization /Storage
►Biotransformation
►Elimination


Слайд 5

Слайд 6

Слайд 7

For most majority of drugs BIOAVAILABILITY is equal to 40-70% - Average level If Bioavailability

For most majority of drugs
BIOAVAILABILITY is equal to
40-70%

- Average level
If Bioavailability
< 40% - Low level
< 70% - High level
Слайд 8

Слайд 9

Слайд 10

Слайд 11

Слайд 12

Слайд 13

VOLUME of DESTRIBUTION (Vd) – a hypothetical volume of fluid

VOLUME of DESTRIBUTION (Vd) – a hypothetical volume of fluid into

which the drug is disseminated

Water compartments in the body:
1). EXTRACELLULAR Volume - 14 L
a). PLASMA Volume - 4 L
b). INTERSTITIAL Volume - 10 L
2). INTRACELLULAR Volume - 28 L

Слайд 14

Volume of destruburion (Vd) – is a hypothetical volume of

Volume of destruburion (Vd) –
is a hypothetical volume

of fluid into which
the drug is dissemineted
Water compartments in the body:
1. Extracellular Volume - 14 L
● plasma Volume - 4 L
●interstitial Volume - 10 L
2. Intracellular Volume - 28 L
Слайд 15

Vd is the ratio of the total amount of drug

Vd is the ratio of
the total amount of drug

in the body to
the concentration of drug in plasma:
Vd = D/C or C = D/Vd
D – total amount of drug in the body
C – plasma concentration of drug
Vd = 100 mg / 25 mg/L = 4 L
Vd = 100 mg / 7 mg/L = 14 L
Vd = 100 mg/0.25 mg/L = 400 L
Слайд 16

Слайд 17

Phase I – Metabilic Biotransformation Lipophilic molecules => Polar Molecules

Phase I – Metabilic Biotransformation
Lipophilic molecules => Polar Molecules

by introducing or unmasking a polar functional group, such as –OH or –NH2
a) Utilizing the Cytochrome P-450
b) Not involving the Cytochrome P-450
►Oxidation
►Reduction
► Hydrolysis
Слайд 18

Phase II – Conjugation Reactions with an Endogenous substrate: ●

Phase II – Conjugation Reactions with
an Endogenous substrate:
● Glucuronic

acid
● Sulfuric acid
● Acetic acid
● Amino acid
=> Polar Water-Soluble compounds that are
most often therapeutically inactive
Слайд 19

Enzyme Induction - the ability of some drugs to induce

Enzyme Induction - the ability of some drugs
to induce

CYP-450 by:
? the rate of its synthesis or
? its rate of degradation:
Phenobarbital
Isoniazid
Glucocorticoides
Anticonvulsants
Macrolid antibiotics
Chronic ethanol administration
Steroids
Слайд 20

Enzyme Inhibition - the ability of drugs to inhibit CYP-450

Enzyme Inhibition - the ability of drugs
to inhibit CYP-450 by:
?

the rate of its synthesis or
? its rate of degradation.
Cimetidine and Ketoconazol bind to
the heme iron of CYP-450 and
?Metabolism of Endogenous Substrates and
other coadministered drugs.
Ethinylestradiol
Spironolacton
Allobarbital
Слайд 21

Слайд 22

Clearance of a Drug Cl = Rate of Elimination /

Clearance of a Drug
Cl = Rate of Elimination / C


First-order (exponential ) kinetics
Rate of Elimination = Cl x C

Слайд 23

Steady State Plasma Concentration (Css) Dose Css = ———— or


Steady State Plasma Concentration (Css)
Dose
Css =

———— or Dose = Css x Cl
Cl
!! Doubling the Dose rate would Double the Css
Слайд 24

For drugs with Michaelis-Menten kinetics, elimination changes from 1st Order

For drugs with Michaelis-Menten kinetics, elimination changes from 1st Order to

Zero Order kinetics
over the therapeutic range
Vmax x C
Rate of Elimination = ——————
KM + C
Vmax - the maximum rate of drug elimination
Km - the drug concentration at which
the rate of elimination is 50% of Vmax
Слайд 25

For drugs with 1st order kinetics: Vmax x C Rate

For drugs with 1st order kinetics: Vmax x C
Rate of

Elimination = —————
KM + C
For drugs with Zero Order kinetics over
the therapeutic range:
Vmax x C
Rate of Elimination = ———— = Vmax
C
Слайд 26

Слайд 27

Слайд 28

Слайд 29

50 % of the drug is lost after one T1/2

50 % of the drug is lost after one T1/2
75% -

after 2 T1/2
> 90% - after 4 T1/2
Слайд 30

Слайд 31

Слайд 32

Слайд 33

Слайд 34

Слайд 35

Слайд 36

Слайд 37

Слайд 38

Слайд 39

Слайд 40

Placebo is an inert substance which is given in the

Placebo is an inert substance which
is given in the

garb of a medicine.
Placebo causes some effects up to 20-40% of cases.
It can be:
1) Positive - 84%
2) Negative 5-7%
3) Mix placebo effect - 9-12%
Имя файла: General-pharmacology.pptx
Количество просмотров: 27
Количество скачиваний: 0